PerkinElmer Announces Strategic Acquisition of Arnel Inc.
News Mar 03, 2009
PerkinElmer, Inc. has announced the acquisition of Arnel Inc., a leader in custom engineered solutions for gas chromatography applications in the petrochemical, food and beverage, and industrial hygiene markets.
The acquisition is an important strategic initiative to expand PerkinElmer's chromatography portfolio and strengthen its application-focused expertise to best serve the biofuels and hydrocarbon processing industries.
This acquisition is a natural extension of PerkinElmer's and Arnel's 18 year relationship during which Arnel served as PerkinElmer's exclusive supplier of gas sampling valve solutions. With the completion of this transaction, PerkinElmer expects to accelerate its development and expand its portfolio of application-focused measurement systems tailored for the biofuels, food and beverage, industrial hygiene, and hydrocarbon processing markets.
"PerkinElmer has a deep understanding of our customers' specific industry related challenges, whether these customers are in the pharmaceutical, consumer, or food quality industries," notes Richard Begley, Ph.D., president, PerkinElmer Analytical Sciences.
"Our acquisition of Arnel brings us greater expertise in the hydrocarbon processing industry through differentiated technology in gas chromatography. In addition, we believe that combining Arnel's technologies with PerkinElmer's chromatography capabilities will help our customers develop cleaner, petroleum based products to help reduce their impact on the environment as well as assist in manufacturing more cost effective petroleum products," Dr. Begley added.
Through this acquisition, PerkinElmer continues its ability to provide standard and custom petroleum tailored solutions based upon PerkinElmer's gas chromatography platform. These analyzers include the widest range of refinery/light hydrocarbon gas analyzers (RGA) and natural gas analyzers (NGA) in the industry.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE
Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?
Scientists have developed a successful method to make truly personalized predictions of future disease outcomes for patients with certain types of chronic blood cancers. The study combined extensive genetic and clinical information to predict the prognosis for patients with myeloproliferative neoplasms.
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
International Women Health and Breast Cancer Conference
Jul 03 - Jul 05, 2019
2nd International Conference on Biological & Pharmaceutical Sciences
Jul 12 - Jul 13, 2019